Molecular diagnostics, personalized medicine, and the evolving role of the cytotechnologist: An institutional experience

Acta Cytologica

Volumn 56, Issue 6, 2012, Pages 678-685

  Kane, Lindsey E ^a   Root, Renee R ^a   Voss, Jesse S ^a   Caudill, Jill L ^a   Sorenson, Angela M ^a   Colborn, Lisa K ^a   Halling, Kevin C ^a   Henry, Michael R ^a   Clayton, Amy C ^a   Kipp, Benjamin R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ancillary testing; Cytology; Molecular diagnostics; Molecular pathology

Indexed keywords

BIOLOGICAL MARKER; CD45 ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; EPITHELIAL CELL ADHESION MOLECULE;

ARTICLE; CANCER SCREENING; CHROMOSOME ANALYSIS; CIRCULATING TUMOR CELL; CLINICAL PRACTICE; CYTODIAGNOSIS; CYTOTECHNOLOGIST; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MOLECULAR DIAGNOSIS; MORPHOLOGY; PAPANICOLAOU TEST; PERSONALIZED MEDICINE; PLOIDY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; UTERINE CERVIX CANCER; WART VIRUS;

EID: 84870667353     PISSN: 00015547     EISSN: None     Source Type: Journal    
DOI: 10.1159/000341169     Document Type: Article

References (26)

1. Papanicolaou G, Traut H: The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941; 42: 193-206.
2. Keebler C, Somrak T: The Manual of Cytotechnology, ed 7. Chicago, American Society of Clinical Pathologists, 1993.
3. American Society of Cytopathology: Facing the Future of Cytopathology: Discerning the Future Needs of our Profession. Wilmington, ASC, 2010.
4. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER: American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137: 516-542.
5. Keebler CM: The future role of the cytotechnologist. Acta Cytologica 1977; 21: 655-657. (Pubitemid 8273869)
6. Macconaill LE, Garraway LA: Clinical implications of the cancer genome. J Clin Oncol 2010; 28: 5219-5228.
7. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Myers RP, Blute ML, Zincke H: Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 2001; 91: 2196-2204. (Pubitemid 32476386)
8. Minot DM, Kipp BR, Root RM, Meyer RG, Reynolds CA, Nassar A, Henry MR, Clayton AC: Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with fish. Am J Clinical Pathol 2009; 132: 133-138.
9. Minot DM, Voss J, Rademacher S, Lwin T, Orsulak J, Caron B, Ketterling R, Nassar A, Chen B, Clayton A: Image analysis of HER2 immunohistochemical staining: reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique. Am J Clin Pathol 2012; 137: 270-276.
10. Oberg TN, Voss JS, Lohse CM, Wu TT, Smyrk TC, Zhang L: Comparison of three ki-67 index quantification methods and clinical significance in pancreatic neuroendocrine tumors. Mod Pathol 2012; 25: 447-448.
11. Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, Degnim AC, Visscher DW, Pankratz VS, Hartmann LC: Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat 2010; 121: 431-437.
12. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000; 164: 1768-1775.
13. Halling KC, Kipp BR: Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol 2008; 15: 279-286.
14. Kipp BR, Fritcher EG, del Rosario KM, Stevens CL, Sebo TJ, Halling KC: A systematic approach to identifying urothelial cells likely to be polysomic by fluorescence in situ hybridization. Anal Quant Cytol Histol 2005; 27: 317-322. (Pubitemid 41803490)
15. Barr Fritcher EG, Caudill JL, Blue JE, Djuric K, Feipel L, Maritim BK, Ragheb AA, Halling KC, Henry MR, Clayton AC: Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results. Am J Clin Pathol 2011; 136: 442-449.
16. Halling KC, Kipp BR: Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 2007; 38: 1137-1144. (Pubitemid 47058172)
17. Fritcher EG, Kipp BR, Halling KC, Oberg TN, Bryant SC, Tarrell RF, Gores GJ, Levy MJ, Clayton AC, Sebo TJ, Roberts LR: A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology 2009; 136: 2180-2186.
18. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR: A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 2006; 130: 694-701. (Pubitemid 44423599)
19. Voss JS, Kipp BR, Halling KC, Henry MR, Jett JR, Clayton AC, Rickman OB: Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens. Am J Respir Crit Care Med 2010; 181: 478-485.
20. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW, Hayes DF: Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006; 12: 6403-6409. (Pubitemid 44799711)
21. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26: 3213-3221.
22. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14: 6302-6309.
23. Bennett A, Thompson NN, Holladay B, Bugbee A, Steward CA: ASCP wage and vacancy survey of U.S. medical laboratories. Lab Med 2009; 40: 133-141.
24. Robeznieks A: Feeling the pain. Mod Healthc 2009; 39: 20, 26.
25. Voss J: Expanding the role of cytotechnologists in molecular diagnostics. ASC Bull 2011; 48: 125-129.
26. Root RM, Bridgeman A, Sorenson A, Nelson S, Ihrke J, Colborn L, Halling KC, Henry MR, Clayton A: Expanding the role of cytotechnologists: a cost-effective approach for anatomic pathology at Mayo Clinic. Cancer Cytopathol 2010; 118: 359-360.